Navigation Links
Collexis BiomedExperts.com Achieves 200,000 Registered Users
Date:8/19/2009

COLUMBIA, S.C., Aug. 19 /PRNewswire-FirstCall/ -- Collexis Holdings, Inc. (OTC Bulletin Board: CLXS), a leading developer of semantic technology and knowledge discovery software, announced today that their life science research portal www.BiomedExperts.com has surpassed the 200,000 registered user mark .

(Logo: http://www.newscom.com/cgi-bin/prnh/20090107/CLW051LOGO)

"Achieving 200,000 registered users in less than 18 months is very positive and we expect that the fall research season will continue to allow BiomedExperts to grow at a healthy pace," stated Bill Kirkland, CEO of Collexis. "We are very excited about our latest partnership with the American Institute of Physics and the pending publishing partnerships that are on the horizon. Further our plans to launch additional functionality over the course of the year will only enhance BiomedExpert's position in the life science industry."

"We continue to hear great things about BiomedExperts from the life science community," states Dr. Christian Herzog, M.D., Managing Director for Collexis STM markets. "BiomedExperts has established itself as the social media tool for life science researchers to be seen and to find new collaborators."

Pre-populated with over 1.8 million Pub-Med-based expert profiles, BiomedExperts allows scientists and researchers to directly connect with and explore their own professional contacts, grow their networks and identify researchers with the expertise needed for future collaborations. Through user-friendly search interfaces, potential research collaborators can share data and collaborate with professionals from more than 1,800 organizations and institutions from 137 countries, totaling more than 30 million connections made through the site.

About Collexis Holdings, Inc.

Collexis Holdings, Inc., a leading developer of semantic technology and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with operations in Cincinnati, Ohio, Cologne, Germany and Valparaiso, Chile. Collexis now offers the world's first pre-populated scientific social network for life science researchers, www.biomedexperts.com. Collexis' proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined "fingerprinted" concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as "finding needles in many haystacks." Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis' current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.

Forward-Looking Statements

Some of the statements made in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and include known and unknown risks, uncertainties and other factors, many of which the company is unable to predict or control, that may cause the company's actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks and uncertainties, including risks and uncertainties associated with BiomedExperts.com. These risks and uncertainties are in addition to other factors detailed from time to time in the company's filings with the SEC, including the section entitled "Risk Factors" in its transition report on Form 10-K for the period ended June 30, 2008. The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future performance. The company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.


'/>"/>
SOURCE Collexis Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Collexis BiomedExperts Hits 80,000 Registered Users Within the First Year!
2. Collexis Launches Innovative Reviewer Finder to Enhance the $30 Billion Health Research Grant Industry
3. Collexis Healthcare to Expand Capabilities for Asklepios Group Utilizing Microsoft Solutions
4. Mayo Clinic to Pilot Collexis Expert Profiling
5. InfoLogix Achieves Motorola Enterprise Mobility Validation
6. ENT and Allergy Opens New Office in Hoboken, New Jersey…Practice Achieves Milestone by Bringing on its 100th Physician
7. BioNeutrals Ygiene(TM) Achieves Worlds Fastest Kill Time With a 100% Total Spore Eradication Verified In Independent Sporicidal/Sterilant Test
8. Germgards New Room-Temperature Surgical Instrument Sterilizer Achieves Total Cycle Time of Three Minutes
9. Established Medical Sub-Component Manufacturer Achieves ISO 13485 Certification
10. Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.
11. DST Health Solutions Achieves ISO 9001:2008 Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... For ... assistance management solution to the exhibit floor for the 2017 HIMSS Conference ... , From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... ... 2017 , ... Pharmica Consulting attended CHI's 8th Annual SCOPE ... trial planning and management. Pharmica discussed the importance of effective project management, data ... by Pharmica’s booth were able to demo its cloud-based Resource Management Tool, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists from ... February 21 - 23 in Beaver Creek, CO. It was announced today by Cindy ... year in Beaver Creek, hosting over 60 faculty members and addressing unmet needs of ...
(Date:2/16/2017)... ... 17, 2017 , ... For some cancer survivors, the memories ... Physician researchers at The Marcus Institute of Integrative Health at Thomas Jefferson ... reducing symptoms of traumatic stress in cancer patients and published their results ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017  Noble Capital Markets announced today that ... (Nasdaq: EPIX ). The report was issued ... , PhD. ESSA Pharmaceuticals is a clinical ... cancer (CRPC). Its lead compound EPI-506, is a small ... of the androgen receptor, thereby has potential to overcome ...
(Date:2/16/2017)... Quest Diagnostics (NYSE: DGX ), ... announced that it has been named one of the ... The annual survey designated Quest Diagnostics as ... Pharmacy and Other Services" industry to attain Most Admired ... attain the designation. This is the second consecutive year ...
(Date:2/16/2017)... Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... company, today announced that executive management will participate in ... held February 22-23, 2017. Adrian Adams , Chief ... at 1:35 p.m. local time on Wednesday, February 22, ... for the event may be accessed from the Investors ...
Breaking Medicine Technology: